Skip to Main Content

Author Details

Homer C Adams
Janssen Pharmaceutical Companies of Johnson & Johnson
2009
18
10
PMIDPaper TitleJournal TitlePublished Year
35913648Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma.Target Oncol2022
35688554DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity.J Immunother Cancer2022
35749004Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma.Target Oncol2022
36875718Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas.Cancer Res Commun2022
35945129High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments.Clin Lymphoma Myeloma Leuk2022
32457357Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab.Leukemia2021
33890981Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma.Blood Adv2021
32513686Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.Proc Natl Acad Sci U S A2020
31969333Preclinical Activity of JNJ-7957, a Novel BCMAÿCD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab.Clin Cancer Res2020
32581054CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells.J Immunother Cancer2020
30536810High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.Cytometry A2019
29797251Deep Profiling of the Immune System of Multiple Myeloma Patients Using Cytometry by Time-of-Flight (CyTOF).Methods Mol Biol2018
29720240Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.Arthritis Res Ther2018
29296857Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma.Blood Adv2017
23955590Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR/ABL1 leukemogenic activity.Blood Cancer J2013
22581302A mystery wrapped in an enigma: Matrigel enhancement of mammary cell growth and morphogenesis.J Mammary Gland Biol Neoplasia2012
20819206Regulation of breast cancer cell motility by T-cell lymphoma invasion and metastasis-inducing protein.Breast Cancer Res2010
19366686The rho-specific guanine nucleotide exchange factor Dbs regulates breast cancer cell migration.J Biol Chem2009
  • 1 - 18 of 18

Recommended Authors

Jihye Park
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2015
Number of shared co-authors 0
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Taher Abbasi
Cellworks Group Inc.
Career Start Year 2011
Number of shared co-authors 4
Dipti Vijayan
QIMR Berghofer Medical Research Institute
Career Start Year 2011
Number of shared co-authors 0
Amanda L Christie
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 2
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 1
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Kara L Davis
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Thomas K??hnke
Cancer Institute, Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 2
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 0
Geoffrey Shouse
City of Hope National Medical Center
Career Start Year 2007
Number of shared co-authors 3
Shweta Joshi
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
Donghui Cheng
University of California los angeles
Career Start Year 2003
Number of shared co-authors 0
Arun P Wiita
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 0
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Susan Geyer
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
Ningyan Zhang
Stem Cell Translational Research Center of Tongji Hospital, Tongji University
Career Start Year 2000
Number of shared co-authors 0
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Peter T Sage
Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1998
Number of shared co-authors 0
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 3
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Suzanne Trudel
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1990
Number of shared co-authors 0
Garry P Nolan
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 2
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 1
Kenneth C Anderson
Dana Farber Cancer Institute
Career Start Year 1981
Number of shared co-authors 0
Stephen E Kurtz
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1979
Number of shared co-authors 13
James M Reuben
The University of Texas MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 1

Collaborators

Sagar Lonial
Co-authored papers 2
Brian J Druker
Oregon Health & Science University
Co-authored papers 1
Michele Bombardieri
Co-authored papers 1
Allie Maffit
Oregon Health & Science University
Co-authored papers 1
Sunil Nagpal
Co-authored papers 1
Ted Laderas
Oregon Health & Science University
Co-authored papers 1
Nicola Long
Oregon Health and Science University
Co-authored papers 1
Lauren K Brady
Emory University School of Medicine
Co-authored papers 1
Guang Fan
Oregon Health and Science University
Co-authored papers 1
Pierrette Lo
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Costantino Pitzalis
Co-authored papers 1
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Nicolas F Fernandez
Co-authored papers 1
Clare V LeFave
LabConnect LLC
Co-authored papers 1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Adeeb Rahman
Co-authored papers 1
Marc M Loriaux
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Frances Humby
Co-authored papers 1
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
T David Soong
Janssen Pharmaceutical Research and Development
Co-authored papers 1
Weiwei Wang
Xinhua Hospital, Shanghai Jiaotong University of Medicine School
Co-authored papers 1
Michael T Lewis
Baylor College of Medicine
Co-authored papers 1
Motomi Mori
St Jude Children's Research Hospital.
Co-authored papers 1
Adam J Lamble
Seattle Children's Hospital, University of Washington
Co-authored papers 1
Jennifer N Saultz
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 1
Daniel Auclair
Co-authored papers 1
Alice M Walsh
Co-authored papers 1
Evan F Lind
Oregon Health & Science University
Co-authored papers 1
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 1
Release 1.2